Trials / Terminated
TerminatedNCT02012608
Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy
Glutamine for the Prevention of Radiation Toxicity in Subjects Undergoing Breast Conserving Therapy
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- University of Arkansas · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a single-centered, double-blind, two-arm randomized study to determine if oral glutamine will reduce radiation toxicity for the subjects undergoing Breast Conserving Therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glutamine | Oral glutamine for subjects undergoing breast conserving therapy |
| DRUG | Placebo | For subjects undergoing breast conserving therapy |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2019-04-01
- Completion
- 2019-04-01
- First posted
- 2013-12-16
- Last updated
- 2019-05-29
- Results posted
- 2019-05-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02012608. Inclusion in this directory is not an endorsement.